Author:
Cui H.,Zeng L.,Li R.,Li Q.,Hong C.,Zhu H.,Chen L.,Liu L.,Zou X.,Xiao L.
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference36 articles.
1. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol,2019
2. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights;Xie;Hepatobiliary Surg Nutr,2020
3. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017
4. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial;Zhu;Lancet Oncol,2018
5. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers;Trebeschi;Ann Oncol,2019
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献